InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Wasoff Evan L, Chief Financial Officer. Insider active across 1 company, notably Nexien Biopharma, INC.. Aggregated, 9 disclosures have been recorded. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Wasoff Evan L is Directeur Financier and Chief Financial Officer at Nexien Biopharma, INC. He has 9 filings in total, and the sampled recent filings cover the period from 2021-11-29 to 2024-05-28. The transactions recorded in this recent sample are Attribution, with 0 EUR of purchases and 0 EUR of sales.